Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPI for Palpitations
NCT02826408Completed
- Sponsor
- Jordan Collaborating Cardiology Group
- Start
- Oct 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of rabeprazole (2 arms), sponsored by Jordan Collaborating Cardiology Group. Primary endpoint: Improvement in Palpitations at 2 weeks. Started Oct 2016; status: completed.
02
Drugs
rabeprazole
Beyond the preview
Go deeper on NCT02826408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02826408.